<< Вернуться к списку статей журнала

Том 9 №1 2007 год - Нефрология и диализ

Инфекция мочевой системы у детей (Обзор литературы)

Серова Г.А. Паунова С.С.

Аннотация: Согласно классификации МКБ-10 под инфекцией мочевой системы (ИМС) следует подразумевать воспалительный процесс в мочевой системе без специального указания на этиологию и локализацию. Это понятие объединяет инфекцию мочевыводящих путей и пиелонефрит, представляющий собой неспецифическое, острое или хроническое микробное воспаление в интерстиции и чашечно-лоханочной системе почек с вовлечением в патологический процесс канальцев, кровеносных и лимфатических сосудов.

Для цитирования: Серова Г.А., Паунова С.С. Инфекция мочевой системы у детей (Обзор литературы). Нефрология и диализ. 2007. 9(1):86-91. doi:

Весь текст

Ключевые слова: инфекция мочевой системы (ИМС), пиелонефрит, распространенность, патогенез, визуальные методы диагностики, прокальцитонин, цитокины, терапия ИМС

Список литературы:

1. Бухарин О.В., Гриценко В.А., Вялкова А.А. Факторы уропатогенности бактерий: роль в патогенезе и значение в диагностике пиелонефрита. Нефрология и диализ 2001; 3; 4: 469-475.
2. Возианов А.Ф., Майданник В.Г. Основы нефрологии детского возраста. Киев: Книга плюс 2002: 348 с.
3. Вялкова А.А., Бухарин О.В., Гриценко В.А. и соавт. Современные представления об этиологии микробно-воспалительных заболеваний органов мочевой системы у детей. Нефрология и диализ 2001; 3; 4: 463-469.
4. Игнатова М.С., Вельтищев Ю.Е. Детская нефрология. Ленинград: Медицина 1989; 304-333.
5. Клембовский А.И. Диспластические основы развития нефропатий в детском возрасте. Педиатрия 1989; 1: 53-60.
6. Коровина Н.А., Захарова И.Н., Мумладзе Э.Б., Гаврюшова Л.П. Протокол диагностики и лечения пиелонефрита у детей. М.: 2002: 48 с.
7. Лопаткин Н.А., Пугачев А.Г. Пузырно-мочеточниковый рефлюкс. М.: Медицина 1990; 18-39.Миронов С.П., Касаткин Ю.Н. Детская радиология. М.: 1993: 206 с.
8. Ольхова Е.Б., Копылова Е.М., Пачес О.А., Никитина С.Ю. Ультразвуковое исследование почек при пузырно-мочеточниковом рефлюксе у детей. Эхография 2001; 2; 2: 201-211.
9. Ольхова Е.Б., Крылова Е.М., Ефремова И.И. Возможности ультразвуковой оценки состояния почек при рефлюкс-нефропатии у детей. Эхография 2001; 2; 1: 61-67.
10. Папаян А.В., Савенкова Н.Д. Клиническая нефрология детского возраста. СПб.: 1997: 718 с.
11. Паунова С.С., Кучеренко А.Г. и др. Цитокины в патогенезе рефлюкс-нефропатии у детей. Нефрология и диализ 2003; 3: 207-211.
12. Ратнер М.Я. Современные представления о значении медиаторов в патогенезе фиброза почечного интерстиция. Тер. архив 1997; 12: 87-88.
13. Рентгенодиагностика в медицине. Руководство для врачей в 2 томах (под ред. Босина В.Ф. и Филиппкина М.А.). М.: Медицина 1998; 2: 13-46.
14. Соматические болезни у детей. Руководство для врачей. Под ред. М.С. Игнатовой. М., Оренбург: 2002: 669 с.
15. Хрущева Н.А. и соавт. Роль вирусов Коксаки В при заболеваниях почек и органов пищеварения у детей и экспериментальных животных. Нефрология и диализ 2001; 3; 4: 482-486.
16. Эрман М.В. Нефрология детского возраста. СПб.: 1997: 414 с.
17. Abeysekara C.K., Yasaratna B.M., Abeyanunawardena A.S. Long-term clinical follow up of children with primary vesicoureteric reflux. Indian. Pediatr 2006; 43; 2: 150-154.
18. Afshar K., Papanikolaou F., Malek R., Bagli D., Pippi-Salle J.L., Khoury A. Vesicoureteral reflux and complete ureteral duplication. Conservative or surgical management? J Urol 2005; 173; 5: 1725-1727.
19. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Peadiatr 1999; 103; 4: 843-852.
20. Awad H., el-Safty I., el-Barbary M., Imam S. Evaluation of renal glomerular and tubular functional and structural integrity in neonates. Am J Med Sci 2002; 324; 5: 261-266.
21. Barratt M., Avner E., Harmon W. Pediatric Nephrology. 4th edn. Lippincott Williams & Wilkins 1999: 1412.
22. Becker A., Baum M. Obstructive uropathy. Early Hum Dev 2006; 82; 1: 15-22.
23. Biggi A., Dardanelli L., Pomero G., Cussino P., Noello C., Sernia O., Spada A., Camuzzini G. Acute renal cortical scintigraphy in children with a first urinary tract infection. Pediatr Nephrol 2001; 6; 9: 733-738.
24. Bloomfield P., Hodson E.M., Craig J.C. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev 2005; 25; 1: CD003772.
25. EL Mouedden M., Guy Laurent G., Mingeot-Leclercg M.-P. et al. Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides. Antimicrobial Agents and Chemotherapy 2000; 44; 3: 665-675.
26. Cengiz N., Baskin E., Anarat R., Agras P.I., Yildirim S.V., Tiker F., Anarat A., Saatci U. Glycosaminoglycans in childhood urinary tract infections. Pediatr Nephrol 2005; 20; 7: 937-939.
27. D’Errico G. The role of nuclear medicine in evaluation of vesicoureteral reflux and or reflux nephropathy. Rays 2002; 27; 2: 149-154.
28. Dayan P.S., Hanson E., Bennett J., Langsam D., Miller S. Clinical course of urinary tract infections in infants younger than 60 days of age. Pediatr Emerg Care 2004; 20; 2: 85-88.
29. Deshpande P.V., Verrier-Jones K. An audit of RCP guidelines on DMSA scanning after urinary tract infection. Arch Dis Child 2001; 84; 4: 324-327.
30. Ditchfield M., Grimwood S., Cook K. et al. Time course of transient cortical scintigraphic defects associated with acute pyelonephritis. Pediatr Radiol 2002; 32; 12: 849-852.
31. Dressler G., Woolf А. Pax2 in development and renal disease. Int J Dev Biol 1999; 43: 463-468.
32. Elmore J.M., Scherz H.C., Kirsch A.J. Dextranomer/hyaluronic acid for vesicoureteral reflux: success rates after initial treatment failure. J Urol 2006; 175; 2: 712-715.
33. Fanos V., Cataldi L. Antibiotics or surgery for vesicoureteric reflux in children. Lancet 2004; 364; 9446: 1720-1722.
34. Garcia F., Nager A. Jaundice as an Early Diagnostic Sign of Urinary Tract Infection in Infancy. Pediatrics 2002; 109: 5: 846-851.
35. Garin E.H., Olavarria F., Garcia Nieto V., Valenciano B., Campos A., Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatr 2006; 117; 3: 626-632.
36. Gbadegesin R.A., Cotton S.A., Watson C.J., Brenchley P.E., Webb N.J. Association between ICAM-1 Gly-Arg polymorphism and renal parenchymal scarring following childhood urinary tract infection. Int J Immunogenet 2006; 33; 1: 49-53.
37. Georgaki-Angelaki H., Kostaridou S., Daikos G.L., Kapoyiannis A., Veletzas Z., Michos A.G., Syriopoulou V.P. Long-term follow-up of children with vesicoureteral reflux with and without antibiotic prophylaxis. Scand J Infect Dis 2005; 37: 11-12: 842-845.
38. Grmek M., Fettich J. The importance of follow-up of children with vesicoureteral reflux grade 1. Acta Paediatr 2003; 92; 4: 435-438.
39. Gurgoze M.K., Akarsu S., Yilmaz E., Godekmerdan A., Akca Z., Ciftci I., Aygun A.D. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 2005; 20; 10: 445-448.
40. Hansson S., Martinell J, Stokland E., Jodal U. The natural history of bacteriuria in childhood. Infect Dis Clin North Am 1997; 11; 3: 499-512.
41. Hassan J.M., Pope J.C. 4th, Brock J.W. 3rd, Adams M.C. Vesicoureteral reflux in patients with posterior urethral valves. J Urol 2003; 170; 4; Pt 2: 677-680.
42. Heidenreich A., Ozgur E., Becker T., Haupt G. Surgical management of vesicoureteral reflux in pediatric patients. World J Urol 2004; 22; 2: 96-106.
43. Hellivell R.J., Adams L.F., Mitchell M.D. Prostaglandin synthases: recent developments and novel hypothesis. Prostaglandins Leukot Essent Fatty Acids 2004; 70; 2: 101-113.
44. Hoberman A., Charron M., Hickey R.W. et al. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 2003; 348; 2: 195-202.
45. Holmdahl G., Sillen U. Boys with posterior urethral valves: outcome concerning renal function, bladder function and paternity at ages 31 to 44 years. J Urol 2005; 174; 3: 1031-1034.
46. Huicho L., Campos-Sanchez M., Alamo C. Metaanalysis of urine screening tests for determining the risk of urinary tract infection in children. Pediatr Infect Dis J 2002; 21; 1: 1-11.
47. Ismaili K., Hall M., Piepsz A., Wissing K.M., Collier F., Schulman C., Avni F.E. Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study. J Pediatr 2006; 148; 2: 222-227.
48. Jakobsson B., Jacobson S., Hjalmas K. Vesico-ureteric reflux and other risk factors for renal damage: identification of high- and low-risk children. Acta Paediatr Supp 1999; 88; 1: 31-39.
49. Jakobsson B.J., Hansson S. Minimum incidence and diagnostic rate of fist urinary tract infection. Pediatrics 1999; 104; 2: 222-226.
50. James-Ellison M.Y., Roberts R., Verrier-Jones K., Williams J.D., Topley N. Mucosal immunity in the urinary tract: changes in sIgA, FSC and total IgA with age and in urinary tract infection. Clin Nephrol 1997; 48; 2: 69-78.
51. Jantunen M.E., Saxen H. et al. Recurrent urinary tract infections in infancy: relapses or reinfections. J Infect Dis 2002; 185; 3: 375-379.
52. Jones J., Walker R. Integrins: a role as cell signaling molecules. Mol Pathol 1999; 52; 4: 208-213.
53. Kontiokari T., Salo J., Eerola E., Uhari U. Cranberry juice and bacterial colonization in children - A placebo-controlled randomized trial. Clinical Nutrition 2005; 24; 6: 1065-1072.
54. Lepor N.E. A review of pharmacologic interventions to prevent contrast-induced nephropathy. Rev Cardiovasc Med 2003; 4 (Suppl 5): S34-42.
55. Lin D.S., Huang S.H., Lin C.C. et al. Urinary tract infection in febrile infants younger than eight weeks of age. Pediatrics 2000; 105; 2: E20.
56. Liu Y., Black M.A., Caron L., Camesano T.A. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol Bioeng 2006; 93; 2: 297-305.
57. Lopez Pereira P., Espinosa L., Martinez Urrutina M.J., Lobato R., Navarro M., Jaureguizar E. Posterior urethral valves: prognostic factors. BJU Int 2003; 91; 7: 687-690.
58. Mahant S., Friedman J., MacArthur C. Renal ultrasound findings and vesicoureteral reflux in children hospitalised with urinary tract infection. Arch Dis Child 2002; 86; 6: 419-420.
59. Marild S., Hansson S., Jodal U., Oden A., Svedberg K. Protective effect of breastfeeding against urinary tract infection. Acta Paediatr 2004; 93; 2: 164-168.
60. Morcos S.K. Contrast media-induced nephrotoxicity - questions and answeres. Br J Radiol 1998; 71; 844: 357-365.
61. Neeb A., Bissada N.K. Evolving management of pediatric urinary tract infection. J Ark Med Soc 2005; 102; 3: 73-75.
62. Niimura F., Kon V., Ichikawa I. The renin-angiotensin system in the development of the congenital anomalies of the kidney and urinary tract. Curr Opin Pediatr 2006; 18; 2: 161-166.
63. Perez-Brayfield M., Kirsch A.J., Hensle T.W., Koyle M.A., Furness P., Scherz H.C. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux. J Urol 2004; 172; 4 (Pt 2): 1614-1616.
64. Piepsz A. Radionuclide studies in paediatric nephro-urology. European Journal of Radiol 2002; 43; 2: 146-153.
65. Prat C., Dominguez J., Rodrigo D. et al. Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection. Pediatr Infect Dis J 2003; 22; 5: 438-442.
66. Pylkkanen J., Vilska J., Koskimies O. The value of level diagnosis of childhood urinary tract infection in predicting renal injury. Acta Paediatr Scand 1981; 70: 879-883.
67. Remington J.S., Klein J. Infectious diseases of the fetus and newborn. 5th edition Philadelphia: WB Saunders 2001.
68. Report of a Working Group of the Research Unit, Royal College of Physicians. Guidelines for the management of acute urinary tract infection in childhood. Journal of the Royal College of Physicians of London 1991; 25; (Part 1): 36-42.
69. Rovin B. Chemokines as therapeutic targets in renal inflammation. Am J Kidney Dis 1999; 34; 4: 761-767.
70. Ruiz-Ortega M., Esteban V., Suzuki Y., Ruperez M., Mezzano S., Ardiles L., Justo P., Ortiz A., Egido J. Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int Suppl 2003; 86: S21-26.
71. Ruiz-Ortega M., Lorenzo O., Suzuki Y. et al. Proinflammatory actions of angiotensin II. Curr Opin Nephrol Hypertens 2001; 10; 3: 321-329.
72. Ruiz-Ortega M., Ruperez M., Lorenzo O. et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 2002; 82: 12-22.
73. Schlussel R. Cystoscopic correction of reflux. Curr Urol Rep 2004; 5; 2: 127-131.
74. Shlager Т. Urinary tract infections in infants and children. Infect Dis Clin 2003; 17: 353-365.
75. Smolkin V., Koren A., Raz R. et al. Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatr Nephrol 2002; 17; 6: 409-412.
76. Stokland E., Hellstrom M., Hansson S. et al. Reliability of ultrasonography in identification of reflux nephropathy in children. BMJ 1994; 309; 6949: 235-239.
77. Technical report: Urinary Tract Infections in Febrile Infants and Young Children (The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee) Stephen M. Downs Pediatrics 1999; 103; 4: 54.
78. Tullus K., Escobar-Billing R., Fituri O. et al. Soluble receptors to tumor necrosis factor and interleukine-6 in urine during acute pyelonephritis. Acta Paediatr 1997; 86; 11: 1198-1202.
79. Tullus K., Wikstad I. et al. Interleukin-1 alpha and interleikin-1 receptor antagonist in urine of children with acute pyelonephritis and relation to renal scaring. Acta Paediatr 1996; 85; 2: 158-162.
80. Uehling D.T., Johnson D.B., Hopkins W.J. The urinary tract response to entry of pathogens. World J Urol 1999; 17; 6: 351-358.
81. Urinary Tract Infection: Old and New Concepts. The Pediatric Clin of North America 1995; 42; 6: 1433-1459.
82. Viciosj M.-A., Garaud J.-J., Reglier-Poupet H. et al. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro. Eyropean Cytokine Network 1998; 9; 3: 247-254.
83. Wald E. Urinary tract infections in infants and children: a comprehensive overview. Curr Opin Pediatr 2004; 16; 1: 85-88.
84. Wang J., Konda R., Sato H. et al. Clinical significance of urinary interleukin-6 in children with reflux nephropathy. J Urol 2001; 165; 1: 210-214.
85. Wennerstrom M., Hansson S., Jodal U., Stokland E. Primary and acquired renal scarring in boys and girls with urinary tract infection. J Pediatr 2000; 136; 1: 30-34.
86. Westwood M., Whiting P., Cooper J., Watt I., Kleijnen J. Further investigation of confirmed urinary tract infection (UTI) in children under five years: a systematic review. BMC Pediatr 2005; 5; 1: 2-6.
87. Wong W., Singh А.K. Urinary cytokines: clinically useful markers of chronic renal disease progression? Current Opinion in nephrology and hypertension. 2001; 10; 6: 807-811.
88. Woolf A.S. A molecular and genetic view of human kidney and urinary tract malformations. Kidney Int 2000; 58; 2: 500-512.
89. Woolf А.S. The Life of the Human Kidney Before Birth: Its Secrets Unfold. Pediatric Research. 2001; 49; 1: 8-10.
90. Yeretsian R.A., Blodgett T.M., Branstetter B.F. 4th, Roberts M.M., Meltzer C.C. Teflon-induced granuloma: a false-positive finding with PET resolved with combined PET and CT. Am J Neuroradiol 2003; 24; 6: 1164-1166.
91. Zafriri D., Ofek I., Adar R., Pocino M., Sharon N. Inhibitory activity of cranberry juice on adherence of type I and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989; 33; 1: 92-98.
92. Zorc J., Kiddoo D., Shaw K. Diagnosis and Management of Pediatric Urinary Tract Infections. Clin Microbiol Rev 2005; 18; 2: 417-422.

Другие статьи по теме

• Патогенетическая роль тромбоцитарного оксида азота в формировании нефропатий у детей
• К патогенезу диализного перитонита
• Состояние иммунной системы при идиопатическом нефротическом синдроме (Лекция)
• Роль вирусной инфекции в патогенезе гломерулонефрита у детей. Современные подходы к иммунокорригирующей терапии (Лекция)